Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in

Jonas K Eriksson1, Lennart Jacobsson2, Karin Bengtsson2

  • 1Clinical Epidemiology Unit and Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

Insights

Patients with ankylosing spondylitis (AS) face a 30%-50% higher risk of cardiovascular events compared to the general population. This risk is similar for stroke but lower for acute coronary syndromes and thrombotic events than in rheumatoid arthritis (RA).

Area of Science:

  • Rheumatology
  • Cardiology
  • Epidemiology

Background:

  • Ankylosing spondylitis (AS) and rheumatoid arthritis (RA) are chronic inflammatory conditions.
  • Cardiovascular (CV) disease is a significant concern in patients with inflammatory arthropathies.
  • Understanding CV risk phenotypes in AS and RA is crucial for patient management.

Purpose of the Study:

  • To compare the incidence of cardiovascular events between patients with AS, RA, and the general population.
  • To analyze CV event risk by specific phenotypes (acute coronary syndromes, thromboembolic events, stroke).

Main Methods:

  • Utilized national registries to identify cohorts of AS (n=5358), RA (n=37,245), and matched general population subjects (n=25,006).
  • Followed cohorts from 2006-2011 until December 31, 2012, for incident CV events.
  • Calculated age/sex-standardized incidence rates and relative risks using Cox proportional hazards models.

Main Results:

  • Patients with AS showed a 1.3-fold increased risk for acute coronary syndromes (ACS) and a 1.4-fold increased risk for thromboembolic events compared to the general population.
  • Patients with RA had a 1.7-fold increased risk for ACS and a 1.8-fold increased risk for thromboembolic events.
  • Both AS and RA patients exhibited a 1.5-fold increased risk for stroke compared to the general population.

Conclusions:

  • Prevalent AS patients have a 30%-50% increased risk of incident CV events.
  • Compared to RA patients, AS patients had a similar risk increase for stroke but a lower risk for ACS and thrombotic events.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
775
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
653
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
817
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
947
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.5K